Lung Cancer Clinical Trials in Maryland

Showing 361-380 of 718 trials

The Lung Screening, Tobacco and Health Project

NCT03200236

The purpose of this study is to compare intensive telephone counseling (ITC) plus the nicotine patch vs. standard telephone counseling plus the nicotine patch (Usual Care; UC) among current smokers undergoing lung cancer screening. Smoking-related outcomes will be examined at three, six and twelve months post-randomization.

Smoking, TobaccoTobacco-Related CarcinomaTobacco Use+1 more

Georgetown University1,114 participantsStarted May 2017

Washington D.C., District of Columbia, United States • Miami, Florida, United States • Moline, Illinois, United States +4 more locations

TERMINATEDPhase 117 miles

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

NCT04244552

ATRC-101-A01 is a Phase 1b, open-label dose escalation and expansion trial of ATRC-101, an engineered fully human immunoglobulin G, subclass 1 (IgG1) antibody derived from a naturally occurring human antibody. The safety, tolerability, PK, and biological activity of ATRC-101 will be characterized when administered every two weeks (Q2W) or every 3 weeks (Q3W) as a monotherapy or in combination with other anticancer agents.

Breast CancerColorectal CancerOvarian Cancer+13 more

Atreca, Inc.87 participantsStarted Feb 2020

Phoenix, Arizona, United States • Tucson, Arizona, United States • Duarte, California, United States +16 more locations

The Lung Screening, Tobacco and Health Project

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

Lung Cancer Trials in Other Cities

PET Imaging With [18F]F-AraG in Advanced Non-small Cell Lung Cancer (NSCLC)

CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) Therapy

A Study of PRT2527 in Participants With Advanced Solid Tumors

A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

Prospective Clinicogenomic Program

A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

Study of the CD40 Agonistic Monoclonal Antibody APX005M

Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib

A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung

Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies

An Study to Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors

A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy

A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab

Survival Prolongation by Rationale Innovative Genomics

International Lung Screen Trial (ILST)

Other Conditions in Maryland